Molecular Dynamics Study of Conformations of Beta-Cyclodextrin and its
  Eight Derivatives in Four Different Solvents by Khuntawee, Wasinee et al.
Molecular Dynamics Study of Conformations of Beta-Cyclodextrin and its 
Eight Derivatives in Four Different Solvents 
 
Wasinee Khuntawee1,2,3, Mikko Karttunen4, and Jirasak Wong-ekkabut1,2,3,*  
1
Department of Physics, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand  
2
Computational Biomodelling Laboratory for Agricultural Science and Technology  
 (CBLAST), Faculty of Science, Kasetsart University, Bangkok 10900, Thailand  
3Thailand Center of Excellence in Physics (ThEP Center), Commission on Higher Education, Bangkok 
10400, Thailand 
4Department of Chemistry and Department of Applied Mathematics, Western University, 1151 Richmond 
Street, London, Ontario N6A 5B7, Canada 
 
*E-mail addresses: jirasak.w@ku.ac.th (J. Wong-ekkabut)  
 
 
 
 
 
 
 
 
 
 Abstract 
Understanding the atomic level interactions and the resulting structural characteristics is required 
for developing beta-cyclodextrin (βCD) derivatives for pharmaceutical and other applications. The effect 
of four different solvents on the structures of the native βCD and its hydrophilic (methylated βCD; 
MEβCD and hydroxypropyl βCD; HPβCD) and hydrophobic derivatives (ethylated βCD; ETβCD) were 
explored using molecular dynamics (MD) simulations and solvation free energy calculations. The native 
βCD, 2-MEβCD, 6-MEβCD, 2,6-DMβCD, 2,3,6-TMβCD, 6-HPβCD, 2,6-HPβCD and 2,6-ETβCD in 
non-polar solvents (cyclohexane; CHX and octane; OCT) were stably formed in symmetric cyclic cavity 
shape through their intramolecular hydrogen bonds. In contrast, βCDs in polar solvents (methanol; MeOH 
and water; WAT) exhibited large structural changes and fluctuations leading to significant deformations 
of their cavities. Hydrogen bonding with polar solvents was found to be one of the major contributors to 
this behavior: solvent-βCD hydrogen bonding strongly competes with intramolecular bonding leading to 
significant changes in structural stability of βCDs. The exception to this is the hydrophobic 2,6-ETβCD 
which retained its spherical cavity in all solvents. Based on this, it is proposed that 2,6-ETβCD can act as 
a sustained release drug carrier.  
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 1. Introduction 
Cyclodextrins (CDs) are cyclic oligosaccharides (ring-structured sugar compounds) commonly 
used in pharmaceutical and food industry for drug complexes and improved solubility, and as cholesterol 
removers, respectively.1, 2 Perhaps the most famous application of CDs, however, is in the commercial 
odor remover Febreze in which CDs are used to capture “stinky” molecules.3 Three of CDs, alpha CD 
(αCD), beta CD (βCD) and gamma CD (γCD), are naturally occurring and consist of α-(1,4) linked D-
glucopyranose with six, seven or eight units, respectively. The general shape of all CDs is a truncated 
cone with hydrophilic outer surface and hydrophobic interior, Figure 1. Cyclodextrins’ history, 
development and applications have been recently reviewed by Crini.4 
In this work, we use molecular dynamics (MD) simulations and solvation free energy calculations 
to investigate conformational properties of the native βCD, four derivatives of methylated βCD 
(MEβCD), three derivatives of hydroxypropyl βCD (HPβCD), and one ethylated βCD (ETβCD) 
derivative. ETβCD is hydrophobic5 while all the rest are hydrophilic. These systems were studied in four 
different solvents, cyclohexane (CHX), methanol (MeOH), octane (OCT) and water (WAT). The list of 
all systems is provided in Table 1. This focus is primarily motivated by the fact that in pharmaceutical 
applications, renal side effects have been reported for parenteral administration and suggested to be a 
result of poor water solubility.6, 7 Despite previous studies regarding water solubility8-11, complex 
stability12, 13, bioavailability of βCD inclusion complexes10, 14, 15, and improvements by substitutions of the 
hydroxyl groups with various functional groups, the molecular origin of these effects is not known.  
 
 
 
Figure 1: Left: Side-view of native βCD forming a truncated cone, showing the glucose subunit and atom 
name labeling. The rim at C6 is called the primary rim with the associated area A1, while the opposite 
rim, consisting of C2 and C3 is the secondary rim (area A2). Acore denotes the area at the center of the 
cavity. The R groups are varied for the βCD derivatives. R1, R2 and R3 of all seven glucose subunits of the 
native βCD are hydrogen atoms. For the derivatives, R1, R2 or R3 of are replaced by methyl (-CH3), 2-
hydroxypropyl (-CH2CH(OH)CH3) and ethyl (-CH2CH3) group, called methylated βCD, hydroxypropyl 
βCD and ethylated βCD, respectively. Right: Top-view of the βCD showing its hydrophobic cavity. The 
red and green spheres represent oxygen and carbon atoms, respectively. Hydrogen atoms are omitted for 
clarity.  
 Different functionalizations have been reported to alter structural, physicochemical and biological 
properties of βCDs.16, 17 In addition, structural studies of several βCD types using X-ray diffraction and 
computer simulations have been conducted.18-22 As a particular feature, Li et al.23 found that the crystal 
structure of the native βCD is a truncated cone due to intramolecular hydrogen bonds (H-bonds) between 
the R1 and  R2 groups of adjacent glucose subunits (Figure 1). Substitutions by methyl groups at R1 and 
R3, (Figure 1) called 2,6-dimethylated-β-CD (2,6-DMβCD; the numbers correspond to the numbering of 
the oxygen atom linking to those functional groups) narrowed the primary rim but the cavity still retained 
its cyclic shape due to intramolecular H-bonds.24  
Structural characterization of βCD derivatives requires their synthesis which is rather difficult 
since substitutions at R1, R2 and R3 compete with each other (Figure 1).18 Computer simulations offer an 
alternative approach to study structure and conformational changes. For example, Yong et al.22 used MD 
simulations to study the structural properties of HPβCD derivatives with varying numbers and positions 
of substituent groups in water. They found that structural changes in cavity shapes influence their 
interactions with guest ligands and the surrounding solvents and intra-molecular interactions. In another 
MD study, the rate constant for hydrogen bond breaking and reformation between βCDs and water 
around/inside cavity was observed to decrease for MEβCDs in comparison to the native βCD.25 
 Previous experiments have shown that water solubility of MEβCD and HPβCD can be enhanced 
by over 20-fold, compared to the native βCD.26-29 In contrast, the solubility of ETβCD is three orders of 
magnitudes lower than that of the native βCD.5, 30 This change in solubility most likely results from 
changes in intramolecular hydrogen bonding and hydrogen bonds with water. It has been shown, that 
toxicity depends on the number of functional groups and their positions31 and that in drug delivery 
systems modified hydrophilicity due to substitutions results in different drug release profiles. In 
particular, hydrophilic βCD derivatives (see Table 1) can be used as immediate release transporters via 
increasing dissolution rate and adsorption of poorly water-soluble drugs, whereas hydrophobic derivatives 
act as sustained release drug carriers for water-soluble compounds.32 Recent results also show that most 
poorly water-soluble drugs bind strongly to MEβCD and HPβCD derivatives which leads to a significant 
increase in solubility compared to free drugs as well as drugs complexed with the native βCD.17 Several 
studies have also suggested that this improvement might be a result from changes in shape and solvent 
interactions of βCD derivatives33, 34; combination of CD complexation and co-solvation is one of the most 
promising techniques for improvement of drug solubility.26, 34 Using alcohols (e.g. methanol, ethanol, etc.) 
as co-solvents, water solubility of guest ligands has been shown to increase.35 The addition of non-polar 
solvent may also enhance the binding affinity of the guest ligand to the βCD’s cavity.36 Moreover, non-
polar solvents have an important role in the purification process of CDs. In particular, cyclohexane helps 
to separate CDs from non-converted starch.37 The precise molecular level mechanisms remain unresolved 
and thus detailed structural analyses are fundamental to understanding βCDs’ properties. Resolving them 
is the aim of this paper. 
 
2. Methodology 
 2.1) System preparation 
 Structural properties of the native βCD and its derivatives (MEβCD, HPβCD and ETβCD) were 
investigated in four different solvents (water, methanol, octane and cyclohexane) by atomistic MD 
simulations. The initial βCD configuration was taken from a previously relaxed βCD.38 The starting 
structures of the derivatives were prepared from the native structure in which the hydrogen atoms of the 
hydroxyl groups at carbon positions 2-, 6-, 2,6- and 2,3,6- for all seven glucoses subunits were replaced 
by methyl groups, 2-hydroxypropyl groups and ethyl groups for βCD derivatives of MEβCD, HPβCD and 
ETβCD, respectively. The native βCD and eight different βCD derivatives are described in Table 1. 
 
 
 
 
 
 
 
 
 
 Table 1: Details of native βCD and its derivatives. The derivatives are classified into two main groups: 1) 
hydrophilic (MEβCDs and HPβCDs) and 2) hydrophobic (ETβCD) according to their water solubility 
with respect to the native βCD. The position and number of functional groups were varied for MEβCDs 
and HPβCDs. The number in the name of each βCD derivative corresponds to the number of oxygen 
atom connecting to the functional group R. The functional groups were fully substituted for all seven 
glucose subunits. 
 
Model System R1 R2 R3 
a) Native βCD 
1 βCD -H -H -H 
Hydrophilic βCDs    
b) Methylated βCD derivatives 
2 2-MEβCD -CH3 -H -H 
3 6-MEβCD -H -H -CH3 
4 2,6-DMβCD -CH3 -H -CH3 
5 2,3,6-TMβCD -CH3 -CH3 -CH3 
c) Hydroxypropyl βCD derivatives 
6 2-HPβCD -CH2CH(OH)CH3 -H -H 
7 6-HPβCD -H -H -CH2CH(OH)CH3 
8 2,6-HPβCD -CH2CH(OH)CH3 -H -CH2CH(OH)CH3 
Hydrophobic βCDs   
d) Ethylated βCD derivative   
9 2,6-ETβCD -CH2CH3 -H -CH2CH3 
 
  
 The GROMACS 5.1.1 package39 was used to perform the MD simulations. The molecular models 
of native βCD, βCD derivatives, methanol, octane and cyclohexane were represented by the Gromos53a6 
force field;40, 41 we also tested the native βCD system with GLYCAM06 force field42 and the results were 
similar. The partial charges and atom types of substituent groups in MβCD, HPβCD and ETβCD are 
shown in Figure S1. In simulations, the βCD in question was initially positioned at the center of the 
simulation box and fully solvated with 7000 single point charge (SPC) water molecules43, 1728 methanol 
molecules, 1000 octane molecules or 2000 cyclohexane molecules depending on the solvent. The details 
of the simulated systems are shown in Table S1. 
 
 2.2) MD simulations 
 All initial structures were first energy minimized by using the steepest descent algorithm. This 
was followed by an MD simulation with a time step of 2 fs in the NPT (constant particle number, pressure 
and temperature) ensemble. The root mean square displacement (rmsd) of all atoms in the βCD molecules 
relative to their minimized structures was monitored and it was determined that the systems had reached 
equilibrium after 70 ns (Figure S2). Data collection for analysis started after that. The total simulation 
time for each of the systems was 100 ns. The Lennard-Jones and the real-space part of electrostatic 
interactions were cut-off at 1.0 nm. For long-range electrostatic interactions, the particle-mesh Ewald 
(PME) method44-46 was used with the reciprocal-space interactions evaluated on a 0.12 nm grid with cubic 
interpolation of order four. The P-LINCS algorithm was used to constrain all bond lengths.47 Isotropic 
pressure coupling was applied using the Berendsen algorithm48 at 1 bar with a time constant of 3.0 ps and 
compressibility of 4.5 × 10−5 bar−1. The Parrinello-Donadio-Bussi velocity rescale thermostat algorithm 
was applied independently for βCD and water at 298 K.49, 50 Periodic boundary conditions were applied in 
all directions. The above simulation protocol has been previously validated and used for several lipid and 
protein systems, for recent ones, see e.g. Refs.51-54. The Visual Molecular Dynamics (VMD) software was 
used for all molecular visualizations.55 
 
3. Results and discussions 
3.1) Structural changes in solvents 
 Structural changes from the energy-minimized structure were measured by the root mean square 
displacement (rmsd) for all atoms in the βCDs. Figures 2(a)-(i) show the rmsd distributions in different 
solvents. The averages rmsd are shown in Table S2. Fluctuations of the rmsd distributions can be 
discussed in terms of the full width at half maximum (FWHM) of the RMSD distributions, as shown in 
Table S3. The distributions were fitted to a Gaussian model and the FWHM values were calculated using 
𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 = 2√𝑙𝑙𝑙𝑙4 ∙ 𝜎𝜎 where 𝜎𝜎 is the standard deviation. In general, FWHM was lower in non-polar 
solvents than in polar ones with the following exceptions: 2,3,6-TMβCD in OCT, 2-HPβCD in OCT, 6-
HPβCD in OCT and 2,6-ETβCD in CHX and OCT. Interestingly, the FWHM of the hydrophobic 2,6-
ETβCD in polar solvents is smaller than in non-polar solvent. This is in contrast to the hydrophilic 
derivatives as 2,6-DMBCD and 2,6-HPBCD which have their substituent groups at the same positions.  
 The rmsd of the native βCD peaks around 0.11 nm in OCT, and around 0.12 nm, 0.20 nm and 
0.26 nm in CHX, MeOH and WAT, respectively (Figure 2(a) and Table S2). The rmsd value of the native 
βCD in water is similar to the previous MD simulation using the same force field as us (Gromos53a6)56; 
the general βCD structural properties using Gromos53a6 are in agreement with X-ray scattering and 
simulations with other force fields42, 57. Compared to the native βCD in water, the rmsd peak position was 
about 23% smaller in MeOH. This tendency has been reported in previous simulations21, 58, but the 
difference in their results was smaller by about 17%58. This may be due the difference in simulation times 
and solvation: our simulations were performed at higher solvation level and are an order of magnitude 
longer (10 vs 100 ns). In addition, as the rmsd time evolutions in Figure S2 show, structural changes can 
occur even at later times.    
Compared to the native βCD, the peak of the rmsd distribution for βCD derivatives moves to 
higher values in all solvents except MEβCDs in water. For 2,6-ETβCD, the positions of the peaks were in 
the same range with the native βCD although their relative positions changed. For MEβCDs (Figures 
2(b)-(e)), the lowest rmsd was found in non-polar solvents similar to the native βCD. The mono-
substituted 2-MEβCD and 6-MEβCD showed large rmsd in OCT, while the rmsd of the di-substituted 
2,6-DMβCD in CHX and OCT were similar. When the native βCD and MEβCDs were solvated in polar 
solvents, rmsd was increased. Moreover, structural change in WAT was less than in MeOH with the 
exception of 2-MEβCD. The fully substituted 2,3,6-TMβCD showed an increase in rmsd of 0.20-0.35 nm 
without any significant structural changes in different solvents.  
In the case of the HPβCD derivatives, the long chain functional groups of 2-hydroxypropyl 
induced larger change in the rmsd compared to the other βCD types. The rmsds of the 2-HPβCD and 2,6-
HPβCD were small in CHX and large in polar solvents, the largest in OCT for 2-HPβCD and in MeOH 
for 2,6-HPβCD. Similarly to 2,3,6-TMβCD, the structure of 6-HPβCD was relatively insensitive to the 
type of solvent. The peak of the rmsd of 6-HPβCD was in the range of 0.26-0.30 nm.  
Finally, the hydrophobic 2,6-ETβCD was most unchanged in OCT. The structure underwent 
larger changes in CHX and polar solvents. The rmsds of the 2,6-ETβCD in WAT and MeOH were 
similar. 
 
 
Figure 2: (a)-(i) The root mean square displacement (rmsd) distribution of the nine different βCDs in 
different solvents: CHX (black), MeOH (red), OCT (green) and WAT (blue). The polar solvents MeOH 
and WAT induced larger structural changes in βCD derivatives with the exceptions of 2,3,6-TMβCD, 2-
HPβCD and 6-HPβCD. 
 
The root mean square fluctuations (rmsf) of atomic positions with respect to their initial 
coordinates were investigated (Figure 3(a)-(i)). The rmsf of each atom was averaged for the seven 
repeating glucose subunits, see atom labeling in Figure 1. The qualitative features of the rmsf profiles are 
the same in all systems with the exception of 2-HPβCD (Figure 3(f)) in which the middle peak is the 
highest one. In particular, the functional groups at the primary rim (at C6) exhibit more pronounced 
fluctuations compared to the functional groups at the secondary rim (at C2 and C3).  In contrast, for 2-
HPβCD (Figure 3(f)) large fluctuations were observed at the secondary rim at C2 functional groups.  
Figure 3(a) shows that the native βCD exhibits less fluctuations in non-polar solvents. Compared 
to the βCD in WAT, the βCD in MeOH showed smaller fluctuations. This is in agreement with the 
previous simulations of Zhang et al.58 Similarly, the MEβCD derivatives exhibit small fluctuations in non-
polar solvents and increased rmsf in polar solvents. The difference between the rmsf in non-polar and 
polar solvents is shown for 6-MEβCD and 2,6-DMβCD (Figures 3(c) and 3(d)). For all MEβCD 
derivatives, 2-MEβCD displayed largest fluctuations. Among all the three HPβCD derivatives, 2-HPβCD 
has the smallest rmsf. The rmsf of 2-HPβCD has smallest fluctuations in WAT and fluctuations increase 
in CHX, MeOH and OCT.  
 
Figure 3: (a)-(i) The averages of root mean square fluctuations (rmsf) of the nine different βCDs in 
different solvents; CHX (black), MeOH (red), OCT (green) and WAT (blue), the higher fluctuation of 
βCDs structure was mostly found in polar solvents (WAT and MeOH), compared to non-polar solvents 
(OCT and CHX). Only the 2-HPβCD was more stable in WAT.  
 
 3.2) Hydrogen bonding 
In addition, the number of intramolecular hydrogen bonds (H-bond) may have a significant 
impact on the structural stability of βCDs.59-61 The number of hydrogen bonds between the -OR1 group 
and the -OR2 group of the adjacent glucose subunits was monitored in each of the cases. As detailed in 
Figure 4(a), the native βCD formed on average about 7 intramolecular H-bonds in both of the non-polar 
solvents, while only few hydrogen bonds were found in polar solvents. Being solvated in CHX, the 
number of adjacent H-bonds of the -OR1 and -OR2 groups for the native βCD were the same as for the 
βCD derivatives. There is an exception, however: for 2-HPβCD and 2,6-HPβCD, the number of adjacent 
H-bonds for the -OR1 and -OR2 groups are higher than for the native βCD. In OCT, the number of 
adjacent H-bonds was in the same range as in CHX, except for 2-MEβCD and 2-HPβCD. These results 
correspond to the comparison of structural changes in CHX and OCT. In polar solvents, the adjacent H-
bond for the native βCD was smaller than for the βCD derivatives, especially in MeOH. The loss of 
intramolecular H-bonds of βCDs resulted from increased intermolecular H-bonding between the βCDs 
and polar solvents (Table 2). Similar effects were seen in all βCD derivatives albeit with some interesting 
characteristics that will be discussed in the next section in connection with the shape analysis.  
 
Figure 4: (a)-(c) intramolecular hydrogen bonds between the adjacent glucose subunits (shown in Figure 
1):  (a) the -OR1 and -OR2 groups, (b) the -OR1 and -OR1 groups, and (c) the -OR3 and -OR3 groups. 
Figures (d)-(f) show intramolecular hydrogen bonds between the non-adjacent glucose subunits: (d) the-
OR1 and -OR2 groups, (e) the -OR1 and -OR1 groups, and (f) the -OR3 and -OR3 groups. There are no 
hydrogen donors or acceptors in 2,3,6-TMβCD.   
 
Table 2: The number of hydrogen bonds between the βCDs and polar solvents. Error is given as standard 
deviation. 
System 
Average numbers of H-bonds 
MeOH WAT 
βCD 32.8±3.0 42.3±3.1 
2-MEβCD 22.3±2.8 34.0±2.9 
6-MEβCD 21.9±2.8 32.3±3.0 
2,6-DMβCD 15.2±2.3 25.0±2.5 
2,3,6-TMβCD 6.9±1.8 15.2±2.4 
2-HPβCD 29.1±3.3 45.1±3.3 
6-HPβCD 30.9±3.5 44.2±3.4 
2,6-HPβCD 30.1±3.4 47.0±3.8 
2,6-ETβCD 14.8±2.3 23.7±2.5 
 
 
Our results suggest that non-polar solvents (CHX and OCT) may stabilize the structures for most 
of the βCDs except for 2-HPβCD in OCT. The deformation of 2-HPβCD in OCT could be found because 
some substituent flipped toward inside the cavity and interacted with their non-neighbor substituents 
(Figure S3). Moreover, the inclusion of the OCT inside the 2-HPβCD's cavity was not found, while the 
CHX could be bound to the cavity (Figure S3). The inclusion complex of non-polar solvents inside the 
βCDs' cavity may also play role in the βCDs structure stabilization. Interestingly, 2,6-ETβCD shows 
lesser structural changes in OCT as compared to the other βCD derivatives. Molecules of polar solvents, 
water and methanol, may be present inside the cavity interior as shown in Figures S4 and S5. Water 
molecules present inside the native βCD cavity were found similarly to the X-ray crystal structures 62, 63. 
For βCD derivatives, the number of water molecules inside the cavity of difunctionalized βCD derivatives 
was significantly higher than in monofunctionalized βCDs. A few methanol molecules were observed 
inside cavity, except for 2-MEβCD and 2-HPβCD. No methanol molecules were present inside the 
deformed cavity of those βCDs. Molecules of the polar solvents were located at the hydrogen acceptors 
and hydrogen donors of the βCDs, that is, not inside the cavity. Hydrogen bonds with polar solvents were 
formed resulting in structural deformation of βCDs. Polar solvents caused higher fluctuations in βCDs' 
structures, especially for the native βCD and the MEβCD derivatives. The structural changes of βCDs as 
well as their shapes may be factors in altering guest ligands’ binding to the cavity interior. The influence 
of solvents on the βCDs' shapes will be discussed in the next section.  
 
 3.3) Shape of βCDs 
 The radius of gyration ( ) and asphericity (b) were examined to describe sizes and shapes. The 
three principal moments (𝜆𝜆1, 𝜆𝜆2 and 𝜆𝜆3 where 𝜆𝜆12 ≥  𝜆𝜆2 2 ≥  𝜆𝜆32) following the common ordering 
convention) of the 𝑅𝑅𝑔𝑔 tensor were measured. 𝑅𝑅𝑔𝑔 can be given in terms of the principal moments as 𝑅𝑅𝑔𝑔 =
�𝜆𝜆1
2 + 𝜆𝜆22 + 𝜆𝜆32 and asphericity as 𝑏𝑏 = 𝜆𝜆1 − 12 (𝜆𝜆2 + 𝜆𝜆3). For a spherically symmetric object 𝑏𝑏 = 0. 
 To explore the local structural properties, the areas (𝐴𝐴) of core structure (Figure 1) at each rim 
were calculated using 
𝐴𝐴 = 𝜋𝜋
7
∑ 𝑟𝑟𝑖𝑖
27
𝑖𝑖=1 , 
(1) 
where 𝑟𝑟𝑖𝑖 is the distance between the βCD’s center and the group of atoms of interest in glucose subunit i. 
The βCD’s center was determined as the center of mass (COM) of all O1 atoms. The groups of interest 
are: 1) O1 atoms, 2) C6⋅⋅⋅O6⋅⋅⋅R3 groups, and 3) O2⋅⋅⋅R1 groups in glucose subunits. They were used to 
represent the cavity area at the core structure (𝐴𝐴𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐), the primary rim (𝐴𝐴1) and the secondary rim (𝐴𝐴2), 
respectively. The definitions of areas are shown in Figure 1. 
 The averages of 𝑅𝑅𝑔𝑔 and 𝑏𝑏 are shown in Table 3.  The time evolutions of 𝑅𝑅𝑔𝑔 and its three principal 
components (𝜆𝜆1 , 𝜆𝜆2 and 𝜆𝜆3) are plotted in Figure S6. Additionally, snapshots from the final 
configurations at t=100 ns are shown in Figure 5. As compared to the native βCD, the 𝑅𝑅𝑔𝑔 are in the same 
range (0.61-0.65 nm) for the MEβCD and increased for HPβCD and ETβCD. The increase of 𝑅𝑅𝑔𝑔  in water 
is in quantitative agreement with previous simulations of βCD and HPβCD.22 For the different solvents, 
the 𝑅𝑅𝑔𝑔s do not show significant differences. Circularity can be examined by using the three principal 
components; when two of the principal components are equal, the planar structure is circular, the smallest 
value is in the direction along the cylindrical axis. Their time evolutions (Figure S6) suggest that the 
native βCD is very close to circular with the exception of water solution where the two largest principal 
components attain different values after about 10 ns. Regarding all derivatives, the highest degree of 
circularity is observed in CHX. As Figure S6 also shows, it is clear that long simulations times are needed 
to capture structural changes. In addition, in polar solvents (MeOH and WAT) the native βCD showed 
higher asphericity than in non-polar solvents by 22% and 56%, respectively (in Table 2). For the MEβCD 
gR
derivatives in non-polar solvents, the cavity mostly formed a circular shape with the exception of 2,3,6-
TMβCD. The 12-38% difference in 𝜆𝜆1 and 𝜆𝜆2 for 2,3,6-TMβCD in all solvents indicates the cavity to be 
ellipsoidal. This is an agreement with X-ray studies.19 Compared to solvation in CHX, solvation in MeOH 
showed increasing asphericity by 62%, 50% and 68% for 2-MEβCD, 6-MEβCD and 2,6-DMβCD, 
respectively. In the case of the HPβCD derivatives, most of the HPβCDs in non-polar solvents had an 
approximately spherical cavity. In contrast, the HPβCD cavity in polar solvents was elliptical: large 
differences between 𝜆𝜆1 and 𝜆𝜆2 values, in the range of 8-37%, were found, especially for 2-HPβCD in 
MeOH (37%) and OCT (32%). In the case of the di-substituted 2,6-HPβCD, 𝜆𝜆1 and 𝜆𝜆2 showed no 
significant dependence on the type of solvent. However, 𝜆𝜆3 increased to be in the same range with 𝜆𝜆1 and 
𝜆𝜆2 especially when the 2,6-HPβCD was solvated by WAT. The HPβCD derivatives with substitutions at 
both 2- and 6-positions were more spherical than the substitutions at only one of those positions. This is 
in agreement with the simulations of HPβCD derivatives in water.22 Most of the HPβCDs in CHX were 
more spherical than in the other solvents; the 2,6-HPβCD in WAT has the lowest asphericity. The 
spherical shape was highly deformed in OCT and in MeOH in case of 2-HPβCD and the change occurred 
after a significant time (Figure S6). Finally, in case of the 2,6-ETβCD, 𝜆𝜆1 and 𝜆𝜆2 fluctuated in the same 
range independent of the type of solvent. It indicates that the circular cavity of 2,6-ETβCD was 
maintained in all solvents. The 𝜆𝜆3 of the 2,6-ETβCD in CHX and OCT were similar. By comparing in 
CHX, the decrease of 𝜆𝜆3 was found by 19% and 10% when the 2,6-ETβCD was solvated by MeOH and 
WAT, respectively. Interestingly, the 2,6-ETβCD remained spherical in all solvents (𝑏𝑏 ~ 0.08-0.09). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: The effect of solvent on the radius of gyration (𝑅𝑅𝑔𝑔) and asphericity (𝑏𝑏). Most of the βCDs are 
larger and more spherical in non-polar solvents than in polar solvents. Errors are given in terms of 
standard deviation. The errors in  𝑅𝑅𝑔𝑔 and 𝑏𝑏  are less than 0.01 and 0.03, respectively. 
System 
Radius of gyration; 𝑹𝑹𝒈𝒈(nm) Asphericity; 𝒃𝒃 
CHX MeOH OCT WAT CHX MeOH OCT WAT 
βCD 0.62±0.01 0.62±0.01 0.62±0.01 0.60±0.01 0.09±0.01 0.11±0.01 0.09±0.01 0.14±0.02 
2-MEβCD 0.64±0.01 0.61±0.01 0.60±0.01 0.62±0.01 0.09±0.01 0.15±0.02 0.10±0.01 0.13±0.02 
6-MEβCD 0.62±0.01 0.62±0.01 0.61±0.01 0.61±0.01 0.08±0.01 0.12±0.02 0.09±0.01 0.12±0.02 
2,6-DMβCD 0.64±0.01 0.62±0.01 0.64±0.01 0.62±0.01 0.08±0.01 0.13±0.02 0.08±0.01 0.10±0.02 
TMβCD 0.63±0.01 0.63±0.01 0.63±0.01 0.65±0.01 0.13±0.01 0.14±0.01 0.15±0.01 0.11±0.01 
2-HPβCD 0.70±0.01 0.66±0.01 0.65±0.01 0.66±0.01 0.10±0.01 0.16±0.02 0.14±0.02 0.10±0.01 
6-HPβCD 0.64±0.01 0.66±0.01 0.64±0.01 0.65±0.01 0.09±0.02 0.12±0.03 0.09±0.02 0.12±0.03 
2,6-HPβCD 0.72±0.01 0.72±0.01 0.71±0.01 0.69±0.01 0.08±0.02 0.11±0.02 0.08±0.02 0.06±0.01 
2,6-ETβCD 0.67±0.01 0.65±0.01 0.67±0.01 0.64±0.01 0.08±0.01 0.09±0.01 0.08±0.01 0.09±0.01 
 
 
 Figure 5: Superposition of the last MD snapshot of each βCD type in different solvents, the native βCD 
and βCD derivatives in CHX, MeOH, OCT and WAT are represented by the black-, red-, green- and 
blue-stick, respectively. The cyclic drastic deformation was found in polar solvents, especially for the 
2,3,6-TMβCD, 2-HPβCD and 2,6-HPβCD. 
 
 The cavity areas of the core structure (𝐴𝐴𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐), the primary rim (𝐴𝐴1) and the secondary rim (𝐴𝐴2) 
are shown in Figures 6(a)-(i), the definitions for the areas are provided in Figure 1. The results show that 
for all βCD types, 𝐴𝐴𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 does not depend significantly on solvent type. At the rims, the area 𝐴𝐴2 was more 
influenced by the solvent type than 𝐴𝐴1. For the native βCD, the 𝐴𝐴2was larger than 𝐴𝐴1 in non-polar 
solvents. In contrast, the area at the primary rim was larger than at the secondary rim in polar solvents. 
Solvation of the native βCD in MeOH leads to a narrow secondary rim. 
For the MEβCD derivatives (Figure 6(b)-(e)), cavity sizes show dependence on functionalization. 
In non-polar solvents, 𝐴𝐴2 of the 2-MEβCD and 2,6-DMβCD increased to ~1.8 nm2 whereas the native 
βCD and the rest of the MEβCD derivatives had 𝐴𝐴2 ~ 1.4 nm2.  Relatively open secondary rims were 
found in non-polar solvents for 2-MEβCD and 2,6-DMβCD, compared to their primary rims. In polar 
solvents, however, 𝐴𝐴1 and 𝐴𝐴2 were similar for most of the MEβCD derivatives.  
Figure 6(e) shows that there is no solvent effect on the TMβCD cavity size. In case of the 
HPβCD derivatives (Figure 6(f)-(h)), the area of substituted rim was larger than the rim without 
functional groups. Functionalization with long chain of 2-hydroxypropyl resulted in large areas compared 
to the native βCD and the other βCD derivatives. The areas at all parts of 2-HPβCD did not show any 
dependence on the type of solvent and 2-HPβCD had its secondary rim more open than the primary. In 
contrast, the primary rim of 6-HPβCD was more opened in all solvents. When both rims had 
substitutions, 𝐴𝐴2 of 2,6-HPβCD was larger than 𝐴𝐴1 in most of the solvents. The only exception was water. 
For 2,6-ETβCD, the secondary rim was larger in non-polar solvents and 𝐴𝐴1 was equal to 𝐴𝐴2 in polar 
solvents. 
 Shape analysis shows that βCDs in non-polar solvents have mostly spherical cavities whereas 
cavity deformations were found in polar solvents. The type of functionalization also had an influence on 
the cavity shape. Substitution at only one rim showed less circularity compared to the MEβCD and 
HPβCD with functional groups on their both rims. However, no significant changes in the area at the core 
(Figure 1) for different functional groups were observed. However, among the three functional groups, 
substitution with hydroxypropyl showed slightly larger area at the rims, especially at the rim(s) with the 
substituent. 
 
 
Figure 6: The area (Figure 1) at the core (𝐴𝐴𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐), the primary rim (𝐴𝐴1) and the secondary rim (𝐴𝐴2) in the 
presence of different solvents. There was no significant change in 𝐴𝐴𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐  with different solvents or 
functional groups. 𝐴𝐴2 was mostly larger than 𝐴𝐴1 in non-polar solvents.  
 
 Before leaving this section, we discuss the relation between principal components and 
intramolecular hydrogen bonding. The case of native βCD has already been addressed above and so we 
focus on the βCD derivatives. Comparison of the time evolution of the principal moments (Figure S6) 
and the number of hydrogen bonds between the different glucose subunits (Figure 4) reveals the 
stabilizing influence of H-bonds between the adjacent -OR1 and -OR2 groups (Figure S7(a)) on the 
secondary rim, and the destabilizing effect of the H-bonds between the -OR3 groups (Figure 4c,f). In 
particular, when H-bonds between the -OR3 groups exist, fluctuations in the principal moments (Figure 
S6) become very pronounced. That is exemplified by the behavior of all HPβCDs. 2,3,6-TMβCD is 
another special case as it does not have any intramolecular H-bonds and it also shows large fluctuations. 
Side and top views of few of the cases are shown in Figure S7. 
 
 3.4) Solvation free energies 
Solvation free energies (Gsolvation) were estimated using the Molecular Mechanic/Poisson-
Boltzmann Surface Area (MM/PBSA) method.64 Gsolvation is the free energy difference between the solute 
in solvent and vacuum. It is composed of contributions due to electrostatic (Gpolar) and non-electrostatic 
(Gnon-polar) terms. Gpolar is estimated using a Poisson-Boltzmann model. The dielectric constant of the βCDs 
molecule was set to be equal to one.65 The dielectric constants of the solvents were extracted from 
experiments.66 The non-polar contribution depends on the βCD’s geometry. The MM/PBSA calculation 
was performed at the rate of every 1 ns for the last 30 ns of MD trajectory. We would like to mention 
issues. First, MM/PBSA is a so-called end-point method, that is, only the free energy difference between 
two states is considered. Thus, it does not take entropic contributions fully into account. A recent review 
of free energy methods discussing MM/PBSA and alternatives is provided by Hansen and van 
Gunsteren.67 The second issue is that solubility is not determined by solvation free energy alone. To 
properly account for solvation, the free energy of the solid phase should also be taken into account. A 
recent review is provided by Skyner et al..68    
The average Gsolvation, and the components Gpolar and Gnon-polar are shown in Figure 7. The main 
contribution to the free energy was observed to be always due to the polar interactions. The non-polar 
contribution in all cases constituted less than 30% of the total solvation free energy. The lowest non-polar 
contribution in water was found for the native βCD, followed by 6-MEβCD, 2-MEβCD, 2,6-DMβCD, 6-
HPβCD, 2-HPβCD, TMβCD, 2,6-ETβCD and 2,6-HPβCD, respectively. The results in Figure 7 suggest 
that all βCDs favor polar solvents. In bulk water, the order for Gsolvation was TMβCD > 2,6-ETβCD > 2,6-
DMβCD > 6-MEβCD > 2-MEβCD > βCD > 2-HPβCD ~ 6-HPβCD > 2,6-HPβCD. This order correlates 
well with hydrogen bonding (Table 2). The solvation free energies are qualitative agreement with 
experiments using the HPβCD and ETβCD derivatives.26, 30  
  In MeOH, Gsolvation is higher compared to water. The same trend as in water was observed with 
one exception: there was no significant difference in Gsolvation between the HPβCD derivatives. In non-
polar solvents, Gsolvation was observed to be about five times higher than in polar solvents. TMβCD has the 
highest Gsolvation in CHX, followed by the 2,6-ETβCD, 2,6-DMβCD, 6-MEβCD, 6-HPβCD, 2,6-HPβCD, 
2-MEβCD, βCD and 2-HPβCD. The order is the same in OCT. 
 
 
Figure 7:  Solvation free energy, Gsolvation (black), and contributions from polar (red) and non-polar (blue) 
interactions.  For the same type of βCD, Gsolvation was always lowest in WAT, followed by MeOH and 
non-polar solvents, respectively. 
   
4. Conclusions 
In the present work, conformational properties of the native βCD and eight of its derivatives, both 
hydrophilic and hydrophobic types, in four different solvents were investigated by MD simulations. Our 
results show that the polar solvents have strong influence on the structural stability of βCDs: 
intramolecular hydrogen bonds were lost, resulting in deformation of the βCDs' ring and decreased 
structural stability. An interesting exception to this behavior was solvation in octane which induced less 
stability and significant changes in the 2-HPβCD structure. 
Interestingly, the hydrophobic 2,6-ETβCD structure showed high rigidity and the spherical shape 
of the cavity remained intact in all solvents. We propose that this high stability, which correlates well 
with its high ligand-binding affinity, may be the reason why 2,6-ETβCD can act as a sustained release 
drug carrier. The effect of polar solvents on the other βCD types was very different and both the positions 
and number of functional groups influenced their shape. In the case of di-substitution at C2 and C6, 
MEβCDs and HPβCDs had spherical cavity, while the mono-substituted ones had elliptical cavities. In 
addition, in non-polar solvents the secondary rim (Figure 1) remained relatively open while it was 
narrowed in polar solvents. The long chain of 2-hydroxypropyl functional groups of the HPβCD 
derivatives resulted in larger areas (Figure 1), especially at the substituted rim. The MM/PBSA 
calculations showed that the solvation free energy of each βCDs type was different depending on their 
chemical functional groups and the numbers of the substituent groups. All βCDs preferred solvation by 
polar solvents. In general, the atomistic details of the conformations in various solvents are highly useful 
for the selection of the appropriate βCDs in pharmaceutical applications and other applications, and in the 
development in drug delivery systems.  
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